 Benjamin Click
Concepts (229)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Crohn Disease | 34 | 2024 | 196 | 12.170 |
Why?
| | Inflammatory Bowel Diseases | 29 | 2024 | 288 | 8.510 |
Why?
| | Colitis, Ulcerative | 13 | 2024 | 105 | 3.660 |
Why?
| | Biological Products | 9 | 2023 | 171 | 2.680 |
Why?
| | Recurrence | 14 | 2024 | 941 | 2.200 |
Why?
| | Colonoscopy | 8 | 2024 | 204 | 2.110 |
Why?
| | Ustekinumab | 8 | 2024 | 12 | 2.080 |
Why?
| | Gastrointestinal Agents | 6 | 2024 | 60 | 1.880 |
Why?
| | Ileum | 10 | 2023 | 92 | 1.350 |
Why?
| | Health Expenditures | 3 | 2020 | 171 | 0.900 |
Why?
| | Colon | 8 | 2023 | 233 | 0.870 |
Why?
| | Adult | 36 | 2024 | 30658 | 0.850 |
Why?
| | Delivery of Health Care | 2 | 2020 | 835 | 0.840 |
Why?
| | Postoperative Complications | 8 | 2023 | 2150 | 0.820 |
Why?
| | Tumor Necrosis Factor-alpha | 5 | 2021 | 1138 | 0.820 |
Why?
| | Health Care Costs | 3 | 2020 | 381 | 0.810 |
Why?
| | Retrospective Studies | 22 | 2024 | 12548 | 0.800 |
Why?
| | Diverticulitis | 1 | 2022 | 7 | 0.800 |
Why?
| | Hypoalbuminemia | 1 | 2021 | 26 | 0.760 |
Why?
| | Humans | 62 | 2024 | 115047 | 0.740 |
Why?
| | Dermatologic Agents | 1 | 2021 | 57 | 0.730 |
Why?
| | Cost of Illness | 2 | 2020 | 254 | 0.720 |
Why?
| | Remission Induction | 5 | 2024 | 233 | 0.700 |
Why?
| | C-Reactive Protein | 4 | 2016 | 363 | 0.700 |
Why?
| | Patient Acceptance of Health Care | 4 | 2020 | 679 | 0.690 |
Why?
| | Anastomosis, Surgical | 5 | 2023 | 137 | 0.680 |
Why?
| | Patient-Centered Care | 3 | 2019 | 474 | 0.680 |
Why?
| | Proctocolectomy, Restorative | 4 | 2024 | 19 | 0.680 |
Why?
| | Gastric Bypass | 1 | 2020 | 93 | 0.640 |
Why?
| | Health Resources | 2 | 2018 | 122 | 0.630 |
Why?
| | Small Molecule Libraries | 1 | 2019 | 80 | 0.620 |
Why?
| | Colonic Pouches | 3 | 2024 | 14 | 0.620 |
Why?
| | Demyelinating Diseases | 1 | 2019 | 75 | 0.610 |
Why?
| | Bariatric Surgery | 1 | 2020 | 162 | 0.590 |
Why?
| | Colitis | 1 | 2020 | 226 | 0.590 |
Why?
| | Antibodies, Monoclonal, Humanized | 4 | 2024 | 665 | 0.590 |
Why?
| | Obesity, Morbid | 1 | 2020 | 198 | 0.570 |
Why?
| | Adenoma | 1 | 2018 | 187 | 0.540 |
Why?
| | Colonic Neoplasms | 1 | 2018 | 222 | 0.520 |
Why?
| | Costs and Cost Analysis | 1 | 2016 | 196 | 0.520 |
Why?
| | Eosinophilia | 1 | 2017 | 186 | 0.510 |
Why?
| | Middle Aged | 24 | 2024 | 26830 | 0.510 |
Why?
| | Quality Improvement | 2 | 2020 | 953 | 0.500 |
Why?
| | Prospective Studies | 14 | 2022 | 6232 | 0.490 |
Why?
| | Asymptomatic Diseases | 1 | 2015 | 75 | 0.490 |
Why?
| | Hypertriglyceridemia | 1 | 2015 | 34 | 0.490 |
Why?
| | Gastrointestinal Tract | 1 | 2017 | 169 | 0.490 |
Why?
| | Blood Component Removal | 1 | 2015 | 29 | 0.480 |
Why?
| | Anti-Inflammatory Agents | 2 | 2017 | 451 | 0.470 |
Why?
| | Ileostomy | 3 | 2023 | 18 | 0.470 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2017 | 231 | 0.470 |
Why?
| | Constriction, Pathologic | 4 | 2023 | 210 | 0.470 |
Why?
| | Quality of Life | 10 | 2022 | 2359 | 0.460 |
Why?
| | Pancreatitis | 1 | 2015 | 107 | 0.460 |
Why?
| | Severity of Illness Index | 7 | 2018 | 2551 | 0.450 |
Why?
| | Antibodies, Monoclonal | 2 | 2024 | 1268 | 0.450 |
Why?
| | Male | 33 | 2024 | 55735 | 0.440 |
Why?
| | Risk Factors | 10 | 2023 | 8642 | 0.440 |
Why?
| | Sweet Syndrome | 2 | 2023 | 7 | 0.420 |
Why?
| | Mental Disorders | 2 | 2017 | 897 | 0.410 |
Why?
| | Female | 32 | 2024 | 59617 | 0.400 |
Why?
| | Hospitalization | 3 | 2020 | 1755 | 0.390 |
Why?
| | Colorectal Neoplasms | 1 | 2018 | 617 | 0.380 |
Why?
| | Cecum | 2 | 2023 | 32 | 0.370 |
Why?
| | Disease Progression | 6 | 2022 | 2389 | 0.370 |
Why?
| | Registries | 8 | 2022 | 1763 | 0.360 |
Why?
| | Anemia | 3 | 2016 | 144 | 0.350 |
Why?
| | Aged | 12 | 2023 | 19122 | 0.350 |
Why?
| | Dilatation | 2 | 2020 | 60 | 0.340 |
Why?
| | Endoscopy | 2 | 2023 | 246 | 0.340 |
Why?
| | Telemedicine | 1 | 2018 | 665 | 0.340 |
Why?
| | Drug Monitoring | 2 | 2022 | 184 | 0.340 |
Why?
| | Pennsylvania | 6 | 2018 | 94 | 0.330 |
Why?
| | Anus Diseases | 2 | 2020 | 7 | 0.320 |
Why?
| | Young Adult | 9 | 2023 | 10498 | 0.300 |
Why?
| | Treatment Outcome | 7 | 2023 | 9123 | 0.290 |
Why?
| | Biological Therapy | 3 | 2022 | 26 | 0.290 |
Why?
| | Cost-Benefit Analysis | 2 | 2020 | 544 | 0.290 |
Why?
| | Pouchitis | 2 | 2024 | 5 | 0.280 |
Why?
| | Risk | 2 | 2019 | 815 | 0.260 |
Why?
| | Necrosis | 2 | 2023 | 210 | 0.250 |
Why?
| | Brain | 1 | 2017 | 2380 | 0.250 |
Why?
| | Neoplasms | 1 | 2019 | 2106 | 0.250 |
Why?
| | Social Isolation | 1 | 2023 | 52 | 0.220 |
Why?
| | Secondary Prevention | 1 | 2024 | 222 | 0.210 |
Why?
| | Comparative Effectiveness Research | 2 | 2021 | 130 | 0.210 |
Why?
| | Reoperation | 2 | 2022 | 519 | 0.210 |
Why?
| | Propensity Score | 2 | 2020 | 224 | 0.200 |
Why?
| | Mesentery | 1 | 2022 | 53 | 0.200 |
Why?
| | Anus Neoplasms | 1 | 2021 | 24 | 0.190 |
Why?
| | Skin Neoplasms | 2 | 2019 | 758 | 0.190 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2021 | 32 | 0.190 |
Why?
| | Economics, Medical | 1 | 2020 | 4 | 0.180 |
Why?
| | Electronic Health Records | 2 | 2018 | 799 | 0.180 |
Why?
| | Rheumatic Diseases | 1 | 2021 | 49 | 0.180 |
Why?
| | Radiation Injuries | 1 | 2021 | 127 | 0.180 |
Why?
| | Chemoradiotherapy | 1 | 2021 | 187 | 0.170 |
Why?
| | Adolescent | 6 | 2022 | 17864 | 0.170 |
Why?
| | Fibrosis | 2 | 2020 | 454 | 0.170 |
Why?
| | Analgesics, Opioid | 2 | 2018 | 774 | 0.170 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2022 | 202 | 0.170 |
Why?
| | Pulmonary Embolism | 1 | 2022 | 184 | 0.170 |
Why?
| | Intestinal Obstruction | 1 | 2020 | 40 | 0.170 |
Why?
| | Gastrectomy | 1 | 2020 | 83 | 0.170 |
Why?
| | Infliximab | 1 | 2020 | 94 | 0.170 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2022 | 246 | 0.160 |
Why?
| | Combined Modality Therapy | 1 | 2022 | 1127 | 0.160 |
Why?
| | Drug Substitution | 1 | 2019 | 46 | 0.160 |
Why?
| | Venous Thromboembolism | 1 | 2022 | 231 | 0.160 |
Why?
| | Deprescriptions | 1 | 2019 | 27 | 0.160 |
Why?
| | Sigmoidoscopy | 1 | 2018 | 10 | 0.160 |
Why?
| | Multivariate Analysis | 3 | 2018 | 1435 | 0.150 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2023 | 856 | 0.150 |
Why?
| | Health Services Misuse | 1 | 2018 | 36 | 0.150 |
Why?
| | Linear Models | 1 | 2020 | 776 | 0.150 |
Why?
| | Thyroid Neoplasms | 1 | 2021 | 263 | 0.150 |
Why?
| | Pyrroles | 1 | 2019 | 181 | 0.150 |
Why?
| | Lymphoma | 1 | 2019 | 178 | 0.150 |
Why?
| | Piperidines | 1 | 2019 | 162 | 0.150 |
Why?
| | Disease Management | 2 | 2020 | 563 | 0.140 |
Why?
| | Clostridium Infections | 1 | 2017 | 56 | 0.140 |
Why?
| | Dermatology | 1 | 2018 | 86 | 0.140 |
Why?
| | Follow-Up Studies | 4 | 2018 | 4420 | 0.140 |
Why?
| | Skin Diseases | 1 | 2018 | 122 | 0.140 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2021 | 577 | 0.130 |
Why?
| | Models, Organizational | 1 | 2017 | 140 | 0.130 |
Why?
| | Unemployment | 1 | 2016 | 39 | 0.130 |
Why?
| | Drug Prescriptions | 1 | 2018 | 239 | 0.130 |
Why?
| | Risk Assessment | 3 | 2022 | 2976 | 0.130 |
Why?
| | Case-Control Studies | 2 | 2020 | 3015 | 0.130 |
Why?
| | Pyrimidines | 1 | 2019 | 376 | 0.130 |
Why?
| | Intestines | 1 | 2019 | 322 | 0.130 |
Why?
| | Weight Loss | 1 | 2020 | 641 | 0.130 |
Why?
| | Adalimumab | 1 | 2015 | 44 | 0.130 |
Why?
| | Biomarkers | 3 | 2023 | 3419 | 0.120 |
Why?
| | Inflammation | 2 | 2024 | 2485 | 0.120 |
Why?
| | Incidence | 2 | 2018 | 2318 | 0.120 |
Why?
| | Cohort Studies | 3 | 2020 | 4904 | 0.120 |
Why?
| | Cross-Sectional Studies | 1 | 2024 | 4411 | 0.110 |
Why?
| | Kaplan-Meier Estimate | 1 | 2015 | 814 | 0.110 |
Why?
| | Hemoglobins | 1 | 2015 | 315 | 0.110 |
Why?
| | Protein Kinase Inhibitors | 1 | 2019 | 787 | 0.110 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 1812 | 0.110 |
Why?
| | Surveys and Questionnaires | 4 | 2018 | 4631 | 0.110 |
Why?
| | Patient Care Team | 1 | 2017 | 515 | 0.100 |
Why?
| | Melanoma | 1 | 2019 | 622 | 0.100 |
Why?
| | Prognosis | 1 | 2020 | 3334 | 0.100 |
Why?
| | United States | 4 | 2024 | 12227 | 0.100 |
Why?
| | Arthritis, Rheumatoid | 1 | 2020 | 1002 | 0.100 |
Why?
| | Comorbidity | 1 | 2016 | 1457 | 0.100 |
Why?
| | Time Factors | 5 | 2022 | 6141 | 0.080 |
Why?
| | Needs Assessment | 2 | 2022 | 316 | 0.080 |
Why?
| | Diabetes Mellitus | 1 | 2016 | 906 | 0.080 |
Why?
| | Hypertension | 1 | 2016 | 1058 | 0.080 |
Why?
| | Logistic Models | 3 | 2018 | 1839 | 0.080 |
Why?
| | Biopsy | 2 | 2022 | 1046 | 0.070 |
Why?
| | Immunologic Factors | 2 | 2021 | 221 | 0.070 |
Why?
| | Iron Compounds | 2 | 2016 | 5 | 0.070 |
Why?
| | Blood Sedimentation | 2 | 2016 | 34 | 0.070 |
Why?
| | Longitudinal Studies | 3 | 2016 | 2389 | 0.060 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2023 | 29 | 0.060 |
Why?
| | United States Food and Drug Administration | 1 | 2024 | 172 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2022 | 6357 | 0.050 |
Why?
| | Resilience, Psychological | 1 | 2023 | 96 | 0.050 |
Why?
| | Mitomycin | 1 | 2021 | 27 | 0.050 |
Why?
| | Fistula | 1 | 2022 | 27 | 0.050 |
Why?
| | Sutures | 1 | 2022 | 52 | 0.050 |
Why?
| | Operative Time | 1 | 2022 | 106 | 0.050 |
Why?
| | Feces | 1 | 2023 | 373 | 0.050 |
Why?
| | Fluorouracil | 1 | 2021 | 152 | 0.050 |
Why?
| | Liver Cirrhosis | 1 | 2022 | 235 | 0.040 |
Why?
| | Aftercare | 1 | 2022 | 186 | 0.040 |
Why?
| | Colectomy | 1 | 2020 | 86 | 0.040 |
Why?
| | Safety | 1 | 2022 | 297 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 2 | 2020 | 2341 | 0.040 |
Why?
| | Guideline Adherence | 1 | 2023 | 492 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2022 | 746 | 0.040 |
Why?
| | Phenotype | 2 | 2017 | 2815 | 0.040 |
Why?
| | Qualitative Research | 1 | 2023 | 935 | 0.040 |
Why?
| | Anticoagulants | 1 | 2022 | 546 | 0.040 |
Why?
| | Patient Preference | 1 | 2020 | 169 | 0.040 |
Why?
| | Animals | 1 | 2019 | 31867 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 250 | 0.040 |
Why?
| | Laparoscopy | 1 | 2022 | 387 | 0.040 |
Why?
| | Hospitals | 1 | 2022 | 582 | 0.040 |
Why?
| | Survival Rate | 1 | 2021 | 1646 | 0.040 |
Why?
| | Anxiety | 1 | 2023 | 845 | 0.040 |
Why?
| | Pain Measurement | 1 | 2018 | 448 | 0.030 |
Why?
| | Vitamin D Deficiency | 1 | 2017 | 158 | 0.030 |
Why?
| | Depression | 1 | 2023 | 1136 | 0.030 |
Why?
| | Intestinal Mucosa | 1 | 2020 | 528 | 0.030 |
Why?
| | Bacillus subtilis | 2 | 1972 | 58 | 0.030 |
Why?
| | Age Factors | 1 | 2022 | 2894 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2018 | 478 | 0.030 |
Why?
| | Early Detection of Cancer | 1 | 2018 | 339 | 0.030 |
Why?
| | Liver | 1 | 2022 | 1681 | 0.030 |
Why?
| | Bacteriophages | 2 | 1972 | 75 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 1353 | 0.030 |
Why?
| | DNA, Viral | 2 | 1972 | 349 | 0.030 |
Why?
| | Academic Medical Centers | 1 | 2015 | 412 | 0.030 |
Why?
| | Lysogeny | 1 | 1971 | 3 | 0.020 |
Why?
| | Biomedical Research | 1 | 2016 | 585 | 0.020 |
Why?
| | Prevalence | 1 | 2016 | 2255 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2020 | 3118 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2017 | 1477 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2018 | 1812 | 0.020 |
Why?
| | Mutation | 2 | 1972 | 3350 | 0.010 |
Why?
| | DNA Replication | 2 | 1972 | 202 | 0.010 |
Why?
| | Centrifugation, Density Gradient | 2 | 1972 | 40 | 0.010 |
Why?
| | Tritium | 2 | 1972 | 68 | 0.010 |
Why?
| | Uridine | 2 | 1972 | 29 | 0.010 |
Why?
| | Mitomycins | 1 | 1972 | 3 | 0.010 |
Why?
| | Temperature | 2 | 1972 | 578 | 0.010 |
Why?
| | Nitrosoguanidines | 1 | 1971 | 1 | 0.010 |
Why?
| | Cell-Free System | 1 | 1971 | 47 | 0.010 |
Why?
| | Cesium | 1 | 1971 | 16 | 0.010 |
Why?
| | Mutagens | 1 | 1971 | 17 | 0.010 |
Why?
| | Spectrophotometry | 1 | 1971 | 48 | 0.010 |
Why?
| | Culture Media | 1 | 1971 | 155 | 0.010 |
Why?
| | Oxides | 1 | 1971 | 43 | 0.010 |
Why?
| | Muramidase | 1 | 1971 | 72 | 0.010 |
Why?
| | Deuterium | 1 | 1971 | 79 | 0.010 |
Why?
| | Chlorides | 1 | 1971 | 127 | 0.010 |
Why?
| | Viral Proteins | 1 | 1972 | 281 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 1971 | 311 | 0.010 |
Why?
| | Bacteriolysis | 1 | 1972 | 9 | 0.000 |
Why?
| | Transferases | 1 | 1972 | 28 | 0.000 |
Why?
| | Adenine | 1 | 1972 | 220 | 0.000 |
Why?
| | Virus Replication | 1 | 1972 | 393 | 0.000 |
Why?
|
|
Click's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|